StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of Ampio Pharmaceuticals stock opened at $0.22 on Monday. The business has a fifty day simple moving average of […]
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of NYSEAMERICAN:AMPE opened at $0.23 on Friday. The company has a market capitalization of $3.44 million, […]
Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE – Free Report) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 332,200 shares, a decrease of 25.7% from the May 31st total of 446,900 shares. Approximately 2.4% of the shares of the company are short sold. Based on […]
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of NYSEAMERICAN AMPE opened at $0.23 on Thursday. The firm’s 50-day moving average is $0.25 and its two-hundred day […]
Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued on Monday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance About Ampio Pharmaceuticals (Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It […]